Directa Plus (GB:DCTA) has released an update.
Directa Plus, a leading graphene nanoplatelets producer, is facing a crucial vote at the upcoming General Meeting on 27 June 2024, where shareholders will decide on a proposed £6.8 million Fundraise. The company’s Board has issued a stark warning that failure to pass the resolutions could severely impact its growth strategy and financial stability, as alternative emergency funding would likely be on less favorable terms. Shareholders have been urged to vote in favor to ensure the company’s continued development and value generation.
For further insights into GB:DCTA stock, check out TipRanks’ Stock Analysis page.
